We are live on
!
Find out more
ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
2 hedge funds and large institutions have $1.45M invested in Endocyte, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 139 closing their positions.
New
Increased
Maintained
Reduced
Closed
99% less funds holding
Funds holding: 139 → 2 (-137)
99% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 139
100% less capital invested
Capital invested by funds: $1.11B → $1.45M (-$1.1B)
100% less funds holding in top 10
Funds holding in top 10: 8 → 0 (-8)
Holders
2
Holders Change
-137
Holders Change %
-98.56%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
139
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OTC
Opera Trading Capital
Paris,
France
|
+$1.31M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$110M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$94.2M |
| 3 |
BlackRock
New York
|
-$93.7M |
| 4 |
VMI
VHCP Management II
New York
|
-$74.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$62.6M |
